HLA Class II Haplotypes Predict Favorable Outcomes for Patients With Metastatic RCC
Der Urologe- Germany
doi 10.1007/s00120-004-0603-9
Full Text
Abstract
Available in
Categories
Date
September 1, 2004
Authors
Publisher
Springer Nature
doi 10.1007/s00120-004-0603-9
Available in
September 1, 2004
Springer Nature